Recombinant SARS-CoV-2 Fusion Protein Vaccine not checked

Livzon Pharmaceutical Group Inc. · V-01 · V-01 10μg

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
5 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Appearance: creamy white suspension Dosage form: Suspension for injection Strength: 10 μg (0.5mL) /vial Vaccination route: intramuscular injection into the lateral deltoid of the upper arm Vaccination dosage: 10 μg Immunization schedule: two doses, one each on Day 0 and 21 (+7 days), respectively. Storage condition: store at 2\~8°C protected from light Expiry date: 24 months after production date”In the company’s words, NCT05096845 on ClinicalTrials.gov
Tested for
COVID-19 Pandemic (4 trials), COVID19
Main trialPhase 3
“A Global, Multi-center, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Study to Evaluate the Efficacy, Safety, and Immunogenicity of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) in Adults Aged 18 Years and Older”In the company’s words, NCT05096845 on ClinicalTrials.gov
Other names
V-01 · V-01 10μg · V-01 25μg

Other drugs for COVID-19 Pandemic

All 43 drugs for COVID-19 Pandemic

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials5

TrialPhaseCompletesWhat it tests
Phase 3Unknown 8 Feb 2022 Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase III
Phase 3Completed 18 Feb 2022 Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study
Phase 2Unknown 29 Sep 2021 Recombinant SARS-CoV-2 Fusion Protein Vaccine Booster Immunization Study to Evaluate the Safety and Immunogencity
Phase 2Unknown 30 Nov 2022 Immunogenicity and Safety of Sequential Immunization of Recombinant SARS-CoV-2 Fusion Protein Vaccine
Phase 1Completed 18 Feb 2022 Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 20 Nov 2026 · EU trials register (CTIS) updated 20 Nov 2026 · openFDA updated 20 Nov 2026

Follow Recombinant SARS-CoV-2 Fusion Protein Vaccine

Following is part of Solo: you see every change to Recombinant SARS-CoV-2 Fusion Protein Vaccine the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in